NTAD - Journey
The New Therapeutics in Alzheimer's disease study (NTAD for short) has been running for several years. There is still an urgent need for better diagnosis and treatment for dementia. One problem is…
Read the full articleYou might also wanna read
Network-Guided Individualized TMS for BPSD in Alzheimer's Disease: A Double-blind Randomized Controlled Trial
Conditions : Transcranial Magnetic Stimulation; Behavioral and Psychological Symptoms in Alzheimer's Disease; Individualized Navigation Inte
Preventing and Treating Dementia Research Priorities to Accelerate Progress
Final Book Now Available Alzheimer's disease and related dementias (AD/ADRD), a collection of neurodegenerative conditions, take a heavy phy
Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's Disease
Conditions : Alzheimer's Disease(AD) Interventions : Device: Temporal Interference Stimulation Sponsors : First Affiliated Hospital of Zheji
Tests May Hint at Alzheimer's 18 Years Before Diagnosis
Ongoing research into Alzheimer's and dementia offers a beacon of hope. Yet, the journey toward significant breakthroughs is complex and unc
Blood Test Breakthrough Offers Hope for Earlier Alzheimer's Detection
Recent breakthroughs in blood testing technology reveal ways to detect Alzheimer's disease much earlier than before. This could revolutioniz
Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's Biomarkers
Conditions : Alzheimer Disease Interventions : Drug: Lecanemab Sponsors : The Fourth Affiliated Hospital of Zhejiang University School of Me
Comments
Sign in to join the conversation.
No comments yet. Be the first.